Clinical trial of a new treatment for the hepatocellular carcinoma patients with liver cirrhosis - Clinical trial of a new treatment for the hepatocellular carcinoma patients with liver cirrhosis

niversity of Tsukuba0 个研究点目标入组 10 人开始时间: 2016年11月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)Acute hepatitis (2)Patients with HIV infection (3)Patients with a past history of cerebrovascular disease or cardiovascular disease (4)Bone marrow transplant recipients and immunosuppressed patients (5)Patient with plasma protein deficiency (eg. IgA deficiency) (6)Patients complicated with cerebrovascular disease, cardiovascular disease, pulmonary disease, renal disease, gastroenterological disease, hematological disease, and neurological or psychiatric disease (7)Patients with a cancer in other organs (8)Patients with HbA1c(NGSP) higher than 8.0 (9)Patients who is currently pregnant or consider pregnancy prior to the study (10)Patients who participated in another clinical trial within 6 months and received medications having pharmacologic effects on improving liver function or increasing platelet counts (11)Patients who have taken or who is currentry taking thrombopoietic agent (12)Patients with a past history of taking the Eltrombopag (13)Patients with allergic reaction to this medicine (14)Patients with allergic reaction to other medications (15)Patients with a past history of arterial or venous thromboembolism In addition, the patient who is judged to be inappropriate for this study

发起方

niversity of Tsukuba